NSC |
Compound |
Enrichment |
Correlation |
NSC 665104 |
Null |
0.0105972823829604 |
0.4224477 |
NSC 666112 |
Null |
0.0105972823829604 |
0.43232257 |
NSC 67586 |
2-Naphthacenecarboxamide, N-[[(6,7-dihydro-7-oxo-1H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl)amino]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, |
0.0105972823829604 |
0.38199112 |
NSC 677696 |
Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]- tert-butyl ester |
0.0105972823829604 |
0.39393947 |
NSC 681643 |
Camptothecin Derivative |
0.0105972823829604 |
0.23540925 |
NSC 683086 |
Boronic acid, [3-methyl-1-[[1-oxo-4-phenyl- 2-[[(2-quinolinyl)carbonyl]amino]butyl]amino]butyl]- |
0.0105972823829604 |
0.27007793 |
NSC 684496 |
Benzoic acid, 4-[2-(3,6-dioxo-1,4-cyclohexadienyl)ethyl]-, isopropyl ester |
0.0105972823829604 |
0.50872361 |
NSC 699667 |
Null |
0.0105972823829604 |
0.34869112 |
NSC 710716 |
Null |
0.0105972823829604 |
0.46320692 |
NSC 728035 |
1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di |
0.0105972823829604 |
0.14401518 |